Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Plebani

Showing results (391-400 of 470) with videos related to

Pageof 47
Sort By:
Disease Markers|July 1, 1988
Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and ageD Basso, C Fabris, G Del Favero, et al.
The American Journal of Gastroenterology|May 1, 1988
Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approachC Fabris, G Del Favero, D Basso, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 7, 2001
IgE binding to soluble and insoluble wheat flour proteins in atopic and non-atopic patients suffering from gastrointestinal symptoms after wheat ingestionB Simonato, F De Lazzari, G Pasini, et al.
Anticancer Research|November 1, 1993
C-peptide pattern in patients with pancreatic cancerP Fogar, D Basso, M P Panozzo, et al.
Klinische Wochenschrift|October 17, 1989
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseasesM Plebani, D Basso, C Fabris, et al.
Respiratory Medicine|December 6, 2017
Electrical impedance tomography in children with community acquired pneumonia: preliminary dataMarta B Mazzoni, Alessandra Perri, Anna M Plebani, et al.
Oncology|January 1, 1991
Does serum CAR-3 play a role in pancreatic cancer diagnosis?D Basso, M P Panozzo, C Fabris, et al.
Journal of Viral Hepatitis|November 3, 2009
Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistanceG Bortoletto, L Scribano, S Realdon, et al.
Tumori|February 28, 1991
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancerC Ferrara, D Basso, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|June 1, 1992
Urinary phospholipase A2 excretion in chronic pancreatic diseasesC Fabris, D Basso, M P Panozzo, et al.
Pageof 47

Showing results (391-400 of 470) with videos related to

Sort By:
Pageof 47
Disease Markers|July 1, 1988
Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and ageD Basso, C Fabris, G Del Favero, et al.
The American Journal of Gastroenterology|May 1, 1988
Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approachC Fabris, G Del Favero, D Basso, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 7, 2001
IgE binding to soluble and insoluble wheat flour proteins in atopic and non-atopic patients suffering from gastrointestinal symptoms after wheat ingestionB Simonato, F De Lazzari, G Pasini, et al.
Anticancer Research|November 1, 1993
C-peptide pattern in patients with pancreatic cancerP Fogar, D Basso, M P Panozzo, et al.
Klinische Wochenschrift|October 17, 1989
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseasesM Plebani, D Basso, C Fabris, et al.
Respiratory Medicine|December 6, 2017
Electrical impedance tomography in children with community acquired pneumonia: preliminary dataMarta B Mazzoni, Alessandra Perri, Anna M Plebani, et al.
Oncology|January 1, 1991
Does serum CAR-3 play a role in pancreatic cancer diagnosis?D Basso, M P Panozzo, C Fabris, et al.
Journal of Viral Hepatitis|November 3, 2009
Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistanceG Bortoletto, L Scribano, S Realdon, et al.
Tumori|February 28, 1991
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancerC Ferrara, D Basso, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|June 1, 1992
Urinary phospholipase A2 excretion in chronic pancreatic diseasesC Fabris, D Basso, M P Panozzo, et al.
Pageof 47